• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»laboratory automation

Why Basler’s embedded vision system matters for next-generation laboratory automation

By Pallavi Madhiraju on May 24, 2026   Medical Devices & Diagnostics  

Why Basler’s embedded vision system matters for next-generation laboratory automation

Find out how Basler’s GMSL vision system could improve lab automation, imaging workflows, and data handling in life sciences.

Are autonomous labs quietly turning biopharma researchers into scientific strategists?

By Pallavi Madhiraju on May 9, 2026   Features & Analysis  

Are autonomous labs quietly turning biopharma researchers into scientific strategists?

Autonomous labs can run experiments faster. The bigger shift is what happens when biopharma researchers stop executing and start directing.

Can Agilent’s new slide scanner system shift digital pathology from pilot to mainstream in Europe?

By Pallavi Madhiraju on January 24, 2026   Medical Devices & Diagnostics  

Can Agilent’s new slide scanner system shift digital pathology from pilot to mainstream in Europe?

Agilent’s new S540MD slide scanner targets scale and AI integration in European pathology labs. Find out what this means for digitisation strategy.

Recent Posts

  • Why Cartesian Therapeutics’ WestGene pact could intensify the race for autoimmune cell therapy
  • Why FDA alignment could move Alterity’s ATH434 closer to a pivotal MSA test
  • Why TG Therapeutics’ BRIUMVI data could open a new treatment path in myasthenia gravis
  • Harbour BioMed’s HBM7004 China IND acceptance sharpens the race for B7-H4 cancer targets
  • Sensorion’s SENS-601 strategy signals a sharper bet on larger genetic hearing loss markets
  • Can Zetagen’s ZetaMet Phase 2a data change how metastatic breast cancer bone lesions are treated?
  • Why Lilly’s expanded Ebglyss label could reset dosing expectations in atopic dermatitis biologics
  • Enveric Biosciences’ EB-003 push highlights the next battle in neuroplastogen drug development
  • Why Multi Radiance Medical’s MR5 ACTIV PRO clearance matters for tendon pain treatment
  • Entyvio pediatric filing puts Takeda at the centre of the next IBD treatment debate
  • Why a CXCR4 PET/CT tracer could become Pentixapharm’s most important cardiovascular asset
  • Vertanical’s Exilby approval puts cannabis-derived pain drugs under a brighter spotlight
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes